Peptides for Tennis Elbow: Evidence and User Reports
Peptides for tennis elbow (lateral epicondylitis) — BPC-157 claims vs physiotherapy evidence, plus anonymous reports. Not treatment advice.
Anonymous user report. Not medical advice. Peptides discussed are not FDA-approved for the uses described. Editorial process →
Short answer
Tennis elbow is usually a tendinopathy of the forearm extensors at the lateral elbow. First-line care is activity modification and physiotherapy; most cases improve over months. BPC-157 is frequently marketed for elbow tendons online, but human trial evidence for tennis elbow is lacking, and the compound is unapproved and WADA-prohibited. Peptide Confessions does not publish dosing, timing, injection or sourcing guidance.
What users report
Elbow appears inside the broader joint phrase counts on the BPC-157 data report. This site does not yet have a large tennis-elbow-only file. Related reading: tendon repair, shoulder pain, recovery.
When to get help
Locking, numbness, progressive weakness, or pain after a fall need clinical assessment. Persistent symptoms despite rehab deserve review rather than another unapproved vial.
Related topics
data reports:
related peptides:
community guides:
More confessions from the archive
Community Q&A
- Does BPC-157 fix tennis elbow?
- There is no strong human trial evidence that it does. Physiotherapy and load management have the practical evidence base for most cases.
- Are healing peptides allowed in sport?
- BPC-157 and TB-500 are prohibited at all times on the WADA list.
- Does this page give dosing advice?
- Peptide Confessions does not publish dosing, timing, injection or sourcing guidance.
Anonymous first-hand reports plus sourced context — educational only, not medical advice. Editorial policy & corrections.